1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for SIGA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 1998. Start Trial.
Date Value
September 18, 2026 -59.91%
September 17, 2026 -60.12%
September 16, 2026 -60.95%
September 15, 2026 -62.50%
September 14, 2026 -60.01%
September 11, 2026 -62.17%
September 10, 2026 -60.78%
September 09, 2026 -60.18%
September 08, 2026 -58.15%
September 04, 2026 -56.12%
September 03, 2026 -57.52%
September 02, 2026 -57.88%
September 01, 2026 -56.27%
August 31, 2026 -57.62%
August 28, 2026 -57.79%
August 27, 2026 -58.00%
August 26, 2026 -59.05%
August 25, 2026 -60.43%
August 24, 2026 -63.53%
August 21, 2026 -60.66%
August 20, 2026 -61.69%
August 19, 2026 -59.84%
August 18, 2026 -62.04%
August 17, 2026 -60.96%
August 14, 2026 -60.40%
Date Value
August 13, 2026 -62.85%
August 12, 2026 -65.05%
August 11, 2026 -65.60%
August 10, 2026 -62.97%
August 07, 2026 -59.60%
August 06, 2026 -51.33%
August 05, 2026 -45.95%
August 04, 2026 -44.82%
August 03, 2026 -43.73%
July 31, 2026 -43.98%
July 30, 2026 -44.82%
July 29, 2026 -46.04%
July 28, 2026 -47.54%
July 27, 2026 -50.83%
July 24, 2026 -50.11%
July 23, 2026 -50.18%
July 22, 2026 -43.96%
July 21, 2026 -40.82%
July 20, 2026 -40.38%
July 17, 2026 -41.86%
July 16, 2026 -40.54%
July 15, 2026 -39.83%
July 14, 2026 -43.54%
July 13, 2026 -39.61%
July 10, 2026 -41.08%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. -21.89%
Corcept Therapeutics, Inc. 38.21%
Veru, Inc. -32.49%
Johnson & Johnson 58.51%
Eli Lilly & Co. 52.08%